International mpox trial finds no clinical benefit from tecovirimat

An international, randomized, double-blind, placebo-controlled Phase III study—the largest of its kind for mpox—found that tecovirimat did not improve clinical outcomes for adults with clade II mpox compared with placebo, while demonstrating…

Continue Reading

News Source: medicalxpress.com